NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/10/2024
Back to search
Official data from USPTO
NOVAPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/10/2024
Trademark type
Word
Nice classes
1
Filing date
07/07/2016
Registration date
10/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2024
Last transaction
01/10/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2016
First use in commerce
06/30/2016
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
MCDOWELL, MATTHEW
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
SEEGENE, INC.
Representatives
Bryant E. Wade/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for detecting or analyzing genetic material for industrialscientific or laboratory purposes; nucleic acid sequences for amplifying or detecting genetic material for industrialscientific or laboratory purposes; reagents for scientificresearchclinical diagnostic or laboratory use; chemicalbiochemical and biological reagents for amplification and detection of genetic material for industrialscientific or laboratory purposes; reagent kits for use in genomic research; in vitro diagnostic reagents for scientific purposes; reagents for analyzing nucleic acid for industrialscientific or laboratory purposes; chemical reagents for use in genetic research; polymerase for nucleic acid amplifications for scientific or laboratory purposes; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/17/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/16/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/15/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/15/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/10/2017
IUAF
USE AMENDMENT FILED
07/14/2017
EISU
TEAS STATEMENT OF USE RECEIVED
07/14/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/17/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2016
PUBO
PUBLISHED FOR OPPOSITION
11/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/17/2016
ALIE
ASSIGNED TO LIE
10/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/26/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/26/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/26/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/26/2016
DOCK
ASSIGNED TO EXAMINER
09/17/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2016
NWAP
NEW APPLICATION ENTERED
07/11/2016
Continuous trademark protection
Get notified about every new filing that threatens NOVAPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.